Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Edison Investment Research-Archiv vom 08.09.2021

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
08.09.21The Biotech Growth Trust - Performance setback may provide an opportunity203The Biotech Growth Trust (BIOG) is managed by Geoff Hsu of OrbiMed Capital, which is a specialist healthcare investor with 11 offices across the globe including in Hong Kong and Shanghai. The manager...
► Artikel lesen
08.09.21IQE - Currency headwinds affect H121 performance252IQE's H121 results are in line with management guidance given in March that H121 revenue and EBITDA would be similar to H120 levels on a constant currency basis. However, currency headwinds resulted...
► Artikel lesen
08.09.21MPC Capital - Business model optimisation637MPC Capital recorded an 86% y-o-y increase in pre-tax profit to €2.3m and a €1.6m net profit ex minorities in H121 against a €0.5m loss in H120. This was assisted by the focus on high-margin business...
► Artikel lesen
08.09.21Boku - Building on H121 strength271Boku reported H121 results in line with its recent trading update and management believes the company is on track to meet recently raised expectations for FY21. Building on the success of helping merchants...
► Artikel lesen
08.09.21Newron Pharmaceuticals - Evenamide Phase III at 30mg twice daily dose365Newron is developing evenamide as an add-on to existing anti-psychotic therapies to treat poorly managed and refractory schizophrenia. A potentially pivotal Phase II/III study is starting in Europe...
► Artikel lesen